Marcie A. Goldstein

Davis Polk advised the lead book-running managers in connection with the initial U.S. public offering of 6,000,000 common shares of TFI International, Inc. In addition, the underwriters…

Davis Polk advised the underwriters in connection with a $75 million public offering of common stock by RAPT Therapeutics, Inc. RAPT Therapeutics’ common stock is listed on the …

Davis Polk advised the joint book-running managers in connection with the $180 million initial public offering of common stock of Beam Therapeutics Inc. The common stock is listed on the…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the $281.75 million initial public offering by 1Life Healthcare, Inc…

Davis Polk advised the joint book-running managers in connection with an initial public offering of 10,586,316 shares of common stock of Black Diamond Therapeutics, Inc. In addition,…

Davis Polk advised the underwriters in connection with the $528 million SEC-registered offering of 16,000,000 shares of common stock of Grocery Outlet Holding Corp. by certain existing…

Davis Polk advised the underwriters in connection with the SEC-registered offering of 3,152,712 shares of common stock of Applied Therapeutics, Inc., including 411,223 shares of common…

Davis Polk advised the underwriters on the SEC-registered initial public offering by I-Mab of 7,407,400 American depositary shares, each 10 ADSs representing 23 ordinary shares, for total…

Davis Polk advised the lead underwriters on the SEC-registered initial public offering by Molecular Data Inc. of 11,500,000 American Depositary Shares sold by Molecular Data, for gross…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $195.6 million public offering of common stock of Forty Seven, …